Compare Aditya Birla Sun Life Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.3 | 1.86 |
NAV | ₹29.75 | ₹37.81 |
Fund Started | 20 Jun 2019 | 25 Jun 2018 |
Fund Size | ₹837.41 Cr | ₹6455.55 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.3
1.86
NAV
₹29.75
₹37.81
Fund Started
20 Jun 2019
25 Jun 2018
Fund Size
₹837.41 Cr
₹6455.55 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year | -1.98% | -1.54% |
3 Year | 20.44% | 25.69% |
5 Year | 12.34% | 16.06% |
1 Year
-1.98%
-1.54%
3 Year
20.44%
25.69%
5 Year
12.34%
16.06%
Equity | 98.81% | 97.87% |
Cash | 1.19% | 2.13% |
Equity
98.81%
97.87%
Cash
1.19%
2.13%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.47% |
Apollo Hospitals Enterprise Ltd. | 7.14% |
Cipla Ltd. | 6.08% |
Torrent Pharmaceuticals Ltd. | 4.71% |
JB Chemicals & Pharmaceuticals Ltd. | 4.51% |
Abbott India Ltd. | 4.48% |
Ajanta Pharma Ltd. | 4.28% |
Aurobindo Pharma Ltd. | 4.11% |
Fortis Healthcare Ltd. | 3.99% |
Lupin Ltd. | 3.94% |
Sun Pharmaceutical Industries Ltd. | 12.05% |
Cipla Ltd. | 7.90% |
Dr. Reddy's Laboratories Ltd. | 7.82% |
Divi's Laboratories Ltd. | 7.10% |
Mankind Pharma Ltd. | 6.44% |
Lupin Ltd. | 5.78% |
Aurobindo Pharma Ltd. | 5.19% |
Alkem Laboratories Ltd. | 3.66% |
Cohance Lifesciences Ltd. | 3.01% |
Syngene International Ltd. | 2.98% |
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 20 Jun 2019 | 25 Jun 2018 |
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
20 Jun 2019
25 Jun 2018